PF-06651600

PF-06651600 · Pfizer

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for PF-06651600, covering 2016-06-16 to 2025-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term PF-06651600 for the Treatment of Alopecia Areata [Phase 3]